Development of polyethylene glycol-modified gold nanoparticles for the delivery of Lutetium-177- radiopharmaceuticals based on antibodies
- 28 August 2024
- journal article
- review article
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 100
Abstract
No abstract availableKeywords
Funding Information
- National Research and Innovation Agency Republic of Indonesia
- International Atomic Energy Agency
This publication has 138 references indexed in Scilit:
- Radiometal-theranostics: the first 20 years*Journal of Radioanalytical and Nuclear Chemistry, 2022
- Gold Nanostars: Synthesis, Optical and SERS Analytical PropertiesAnalysis & Sensing, 2022
- Antisense RNA Design, Delivery, and Analysis2022
- The Use of the Macrocyclic Chelator DOTA in Radiochemical SeparationsEuropean Journal of Inorganic Chemistry, 2019
- Two decades of SPECT/CT – the coming of age of a technology: An updated review of literature evidenceEuropean Journal of Nuclear Medicine and Molecular Imaging, 2019
- Radiosynthesis, radiochemical, and biological characterization of 177Lu‐labeled diethylenetriamine penta‐acetic acidJournal of Cellular Biochemistry, 2019
- Chemical aspects of metal ion chelation in the synthesis and application antibody‐based radiotracersJournal of Labelled Compounds and Radiopharmaceuticals, 2018
- Rational Design, Development, and Stability Assessment of a Macrocyclic Four‐Hydroxamate‐Bearing Bifunctional Chelating Agent for 89ZrChemMedChem, 2017
- Growth of Monodisperse Gold Nanospheres with Diameters from 20 nm to 220 nm and Their Core/Satellite NanostructuresAdvanced Optical Materials, 2013
- In vitro characterization of 177Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009